Investment
Features
FeesSafety
Academy
More
Pluang+

IMUNON sells ThermoDox rights to VoxelDox, focusing on ovarian cancer trial while retaining future earnings potential.

Company Fundamentals
21 Oct 2026
GlobeNewsWire
View Source
Neutral
IMUNON sells ThermoDox rights to VoxelDox, focusing on ovarian cancer trial while retaining future earnings potential.

IMUNON, Inc. has agreed to sell its rights to ThermoDox, a heat-activated cancer drug, to VoxelDox Therapeutics. VoxelDox plans to develop ThermoDox for glioblastoma treatment and will provide IMUNON with equity, milestone payments up to $16.5 million, and royalties on future sales. This deal allows IMUNON to focus its resources on its lead program, IMNN-001, currently in a Phase 3 trial for advanced ovarian cancer, while maintaining potential long-term financial benefits from ThermoDox. The transaction depends on VoxelDox securing $2.5 million in financing to start a Phase 1 glioblastoma trial.

IMUNON's strategic sale of ThermoDox is the subject, with Pluang's Health sector market data as context. For readers following Health stocks, 65 out of 150 traded US stocks rose while 76 fell as of Oct 21, 2026 18:42 WIB. Notable movers include Abbott Laboratories (ABT) at USD 98.50 with a 1-day change of -4.09%, Danaher Corporation (DHR) at USD 215.50 down 3.80%, and Tango Therapeutics Inc. (TNGX) up 3.76% at USD 26.20.

More News

Royal Caribbean updates gratuity disclosures to clarify optional pre-payment, avoiding consumer confusion.

Royal Caribbean updates gratuity disclosures to clarify optional pre-payment, avoiding consumer confusion.

The BBB National Programs’ National Advertising Division reviewed Royal Caribbean Group's advertising related to gratuities and found the company's recent modifications to be supported. Royal Caribbean clarified in its booking process that gratuities...

Market News
Neutral
13 minutes ago
Deutsche Bank raises Kroger price target to $70 on growth plans and new stores.

Deutsche Bank raises Kroger price target to $70 on growth plans and new stores.

Deutsche Bank increased its price target for Kroger to $70 from $68, reflecting a potential 10.7% upside. Kroger announced strategic growth initiatives including a $5 billion customer-value investment and plans to open 110 new stores by 2029. The com...

Analyst Insights
Bullish
59 minutes ago
Crown Castle Q3 2026 earnings expected with mixed revenue decline but potential EPS growth.

Crown Castle Q3 2026 earnings expected with mixed revenue decline but potential EPS growth.

Crown Castle is set to report its Q3 2026 earnings with Wall Street expecting a 5.9% revenue decline to about $1.01 billion, mainly due to drops in site rental and services revenue. However, some forecasts predict a 7.1% rise in earnings per share to...

Company Fundamentals
Neutral
1 hour ago
PypeServer launches Cloud+ 3.0 to unify HVAC ductwork and piping fabrication in one platform.

PypeServer launches Cloud+ 3.0 to unify HVAC ductwork and piping fabrication in one platform.

PypeServer has released Cloud+ version 3.0, enabling HVAC contractors to manage both ductwork and piping fabrication on a single platform. This update allows seamless tracking from design through installation, integrating with existing design softwar...

Others
Bullish
1 hour ago
Kevel raises $52M to expand AI-driven commerce media infrastructure globally.

Kevel raises $52M to expand AI-driven commerce media infrastructure globally.

Kevel secured $52 million in its largest funding round to date, boosting its AI-powered infrastructure for commerce media networks. The capital will accelerate product innovation, transparent AI decisioning, and global expansion, helping retailers an...

Others
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App